The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Repligen Corp. (NASDAQ: RGEN) closed at $147.55 down -9.26% from its previous closing price of $162.61. In other words, the price has decreased by -$9.26 from its previous closing price. On the day, 3.13 million shares were traded. RGEN stock price reached its highest trading level at $166.73 during the session, while it also had its lowest trading level at $140.19.
Ratios:
For a deeper understanding of Repligen Corp.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.21 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 69.30. For the most recent quarter (mrq), Quick Ratio is recorded 5.56 and its Current Ratio is at 6.65. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Deutsche Bank on June 26, 2024, Upgraded its rating to Buy and sets its target price to $155 from $180 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 02 ’24 when KURIYEL RALF sold 7,148 shares for $159.35 per share. The transaction valued at 1,139,016 led to the insider holds 12,288 shares of the business.
Ralf Kuriyel bought 7,148 shares of RGEN for $1,139,040 on Aug 02 ’24. On Aug 01 ’24, another insider, KURIYEL RALF, who serves as the Senior VP, R&D of the company, sold 4,465 shares for $165.67 each. As a result, the insider received 739,717 and left with 19,261 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGEN now has a Market Capitalization of 8263759360 and an Enterprise Value of 8197465600. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.72 while its Price-to-Book (P/B) ratio in mrq is 4.15. Its current Enterprise Value per Revenue stands at 13.609 whereas that against EBITDA is 103.851.
Stock Price History:
Over the past 52 weeks, RGEN has reached a high of $211.13, while it has fallen to a 52-week low of $110.45. The 50-Day Moving Average of the stock is 6.75%, while the 200-Day Moving Average is calculated to be -10.70%.
Shares Statistics:
For the past three months, RGEN has traded an average of 803.08K shares per day and 885480 over the past ten days. A total of 55.77M shares are outstanding, with a floating share count of 52.01M. Insiders hold about 7.00% of the company’s shares, while institutions hold 101.00% stake in the company. Shares short for RGEN as of 1722384000 were 4392198 with a Short Ratio of 5.47, compared to 1719532800 on 4212117. Therefore, it implies a Short% of Shares Outstanding of 4392198 and a Short% of Float of 9.17.
